Silvano Spinelli
Founder at BiovelocITA Srl
Profile
Silvano Spinelli is the founder of Novuspharma SpA, EOS SpA, and BiovelocITA Srl, which were founded in 1999, 2006, and 2015 respectively.
He held the position of Chief Executive Officer at Novuspharma SpA from 2010 to 2011, and at EOS SpA from 2006 to 2012.
He is currently the Chairman at Alia Therapeutics Srl, Nephris Srl, and a Venture Partner at Sofinnova Partners SAS since 2018.
He previously worked as a Managing Director at CTI BioPharma Corp.
Dr. Spinelli received his undergraduate degree from the University of Pisa in 1976.
Silvano Spinelli active positions
Companies | Position | Start |
---|---|---|
BiovelocITA Srl
BiovelocITA Srl Investment ManagersFinance Biovelocita Srl (Biovelocita) is a venture capital firm founded in 2015 by Silvano Spinelli, Gabriella Camboni and Sofinnova Partners. The firm is headquartered in Milan, Italy. | Founder | 31/12/2014 |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Private Equity Investor | 11/03/2018 |
Nephris Srl
Nephris Srl Miscellaneous Commercial ServicesCommercial Services Nephris Srl provides pre-clinical and research services for kidney diseases. The company is based in Milan, Italy. The Italian company was founded in 2021 by Paolo Fiorina, Francesca D'Addio. The CEO is Maria Gabriella Camboni. | Chairman | - |
Alia Therapeutics Srl
Alia Therapeutics Srl BiotechnologyHealth Technology Alia Therapeutics Srl engages in experimental research activities in the field of biotechnology. It specializes in the identification of new technologies for genome modification. The company was founded by Gianluca Petris, Antonio Casini, and Anna Cereseto and is headquartered in Trento, Italy. | Chairman | - |
Former positions of Silvano Spinelli
Companies | Position | End |
---|---|---|
Novuspharma SpA | Founder | 26/07/2011 |
CTI BIOPHARMA CORP. | Corporate Officer/Principal | 18/08/2005 |
EOS SpA
EOS SpA Pharmaceuticals: MajorHealth Technology EOS SpA engages in the manufacture of biopharmaceutical products. The company was founded by Silvano Spinelli, Gabriella Camboni, Ennio Cavalletti and Jacques Theurillat in June 2006 and is headquartered in Milan, Italy. | Chief Executive Officer | - |
Training of Silvano Spinelli
University of Pisa | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 7 |
---|---|
CTI BioPharma Corp.
CTI BioPharma Corp. Pharmaceuticals: MajorHealth Technology CTI BioPharma Corp. is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of novel targeted therapies for blood-related cancers. It focuses on evaluating pacritinib, its sole product candidate currently in active development, for the treatment of adult patients with myelofibrosis. The company was founded by James A. Bianco, Jack W. Singer, and Louis A. Bianco in September 1991 and is headquartered in Seattle, WA. | Health Technology |
EOS SpA
EOS SpA Pharmaceuticals: MajorHealth Technology EOS SpA engages in the manufacture of biopharmaceutical products. The company was founded by Silvano Spinelli, Gabriella Camboni, Ennio Cavalletti and Jacques Theurillat in June 2006 and is headquartered in Milan, Italy. | Health Technology |
Novuspharma SpA | Health Technology |
BiovelocITA Srl
BiovelocITA Srl Investment ManagersFinance Biovelocita Srl (Biovelocita) is a venture capital firm founded in 2015 by Silvano Spinelli, Gabriella Camboni and Sofinnova Partners. The firm is headquartered in Milan, Italy. | Finance |
Sofinnova Partners SAS
Sofinnova Partners SAS Investment ManagersFinance Sofinnova Partners SA (Sofinnova) is an independent venture capital firm established in 1972 and headquartered in Paris, France. Originally known as Sofinnova, the first venture capital firm created in France, the firm created a U.S. subsidiary in San Francisco in 1976. In 1997, both firms were bought out by their management teams, which become the majority shareholders of the new companies, Sofinnova Partners in Paris and Sofinnova Ventures in San Francisco. | Finance |
Nephris Srl
Nephris Srl Miscellaneous Commercial ServicesCommercial Services Nephris Srl provides pre-clinical and research services for kidney diseases. The company is based in Milan, Italy. The Italian company was founded in 2021 by Paolo Fiorina, Francesca D'Addio. The CEO is Maria Gabriella Camboni. | Commercial Services |
Alia Therapeutics Srl
Alia Therapeutics Srl BiotechnologyHealth Technology Alia Therapeutics Srl engages in experimental research activities in the field of biotechnology. It specializes in the identification of new technologies for genome modification. The company was founded by Gianluca Petris, Antonio Casini, and Anna Cereseto and is headquartered in Trento, Italy. | Health Technology |
- Stock Market
- Insiders
- Silvano Spinelli